9 Masimo SET ® is accurate on dark skin. A peer-reviewed publication using appropriately standardized sensor application sites demonstrated that Masimo RD SET sensors had only a 0.15% difference ...

Masimo’s key technologies include the widely used Masimo SET pulse oximetry, which has improved outcomes in more than 200 million patients worldwide and is recognized by the top U.S. hospitals.

Masimo Corp.’s stock was up by nearly 4% on Monday after Politan Capital Management said it plans to nominate two more ...

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its ...

Masimo Corporation (NASDAQ:MASI) disclosed Friday that it received unsolicited offers from potential acquirers for its ...

Masimo Corp.’s annual shareholder meeting, scheduled for Sept. 19, will determine whether Joe Kiani will remain as chairman of the company he co-founded in 1989. The Irvine maker of non-invasive ...

Joe Kiani remembers the day that everything changed at work. On Feb. 15, 2022, the founder, chairman, and CEO of Masimo announced the $1 billion acquisition of Sound United. While Kiani knew the ...

3 SET ® measures with industry-best SpO 2 accuracy specifications 4 – achieved with Masimo’s flagship RD SET ® sensors – through challenging conditions such as patient motion and low ...

Masimo SET ® originated in Founder and CEO Joe Kiani’s desire to find a way to monitor the oxygen saturation of those most precious of patients – neonatal infants – accurately and reliably ...

3 SET® measures with industry-best SpO2 accuracy specifications4 – achieved with Masimo’s flagship RD SET® sensors – through challenging conditions such as patient motion and low perfusion ...

2 With more than 100 studies demonstrating its ability to outperform other pulse oximetry technologies, 3 SET ® measures with industry-best SpO 2 accuracy specifications 4 – achieved with Masimo’s ...